KD Logo

Abbott Laboratories [ABT] Officer makes an insider purchase of 15,000 shares worth 1.8 million.

Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Abbott Laboratories shares valued at $1,800,000 were purchased by Funck, Jr. Robert E. on Nov 04 ’24. At $120.00 per share, Funck, Jr. Robert E. acquired 15,000 shares.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Also, ALLEN HUBERT L sold 157,421 shares, netting a total of over 18,424,298 in proceeds. Following the sale of shares at $117.04 each, the insider now holds 184,806 shares.

Before that, ALLEN HUBERT L had added 157,421 shares to its account. In a trade valued at $18,715,783, the Officer bought Abbott Laboratories shares for $118.89 each.

As published in their initiating research note from Oppenheimer on October 08, 2024, Abbott Laboratories [ABT] has been an Outperform and the price target has been revised to $130. Analysts at Piper Sandler started covering the stock with ‘”an Overweight”‘ outlook in a report released in mid September. As of July 30, 2024, Edward Jones has decreased its “Buy” rating to a “Hold” for ABT. Earlier on May 30, 2024, Goldman initiated its rating. Their recommendation was “a Buy” for ABT stock.

Analyzing ABT Stock Performance

During the last five days, there has been a surge of approximately 1.70%. Over the course of the year, Abbott Laboratories shares have jumped approximately 4.75%. Shares of the company reached a 52-week high of $121.64 on 03/08/24 and a 52-week low of $99.71 on 07/18/24. A 50-day SMA is recorded $115.24, while a 200-day SMA reached $110.64. Nevertheless, trading volume fell to 5.37 million shares from 5.26 million shares the previous day.

Support And Resistance Levels for Abbott Laboratories (ABT)

According to the 24-hour chart, there is a support level at 114.06, which, if violated, would cause prices to drop to 112.83. In the upper region, resistance lies at 117.01. The next price resistance is at 118.73. RSI (Relative Strength Index) is 48.82 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.74, which suggests the price will decrease in the coming days. Percent R is at 67.06%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.

Most Popular